Targeting the Fanconi Anemia Pathway to Identify Tailored Anticancer Therapeutics

<table>Inhibition of the FA pathway. Strategy for selectively targeting tumor cells by inhibition of the FA pathway by (a) chemosensitization to cross-linking agents or by (b) exploiting specific synthetic lethal interactions.</table>

Anemia

fig1

Figure 1

Figure 1: Targeting the Fanconi Anemia Pathway to Identify Tailored Anticancer Therapeutics 